secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001104659-23-065563
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics registers up to $150M additional ADS sale under ATM facility
--------------------------------------------------------------------------------

- Filed prospectus supplement on May 26, 2023, to sell up to $150M in ADSs via existing Sales Agreement with Cantor Fitzgerald and Oppenheimer.
- Sales agents will receive 3% commission on gross proceeds; offering is an 'at the market' program under Rule 415.
- Company is not obligated to sell any shares; sales at its discretion subject to market conditions.
- The original Controlled Equity Offering agreement was dated June 5, 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/0001104659-23-065563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/tm2317110d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-065563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer